{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:19:45Z","timestamp":1760865585183},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1478-3231.2009.02199.x","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T14:22:21Z","timestamp":1264774941000},"page":"623-632","source":"Crossref","is-referenced-by-count":15,"title":["Lactoferrin protects against concanavalin A-induced liver injury in mice"],"prefix":"10.1111","volume":"30","author":[{"given":"Hao","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chapla","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB1","doi-asserted-by":"crossref","unstructured":"1.\u2002 Tiegs G , Hentschel J , Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.","DOI":"10.1172\/JCI115836"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB2","doi-asserted-by":"crossref","unstructured":"2.\u2002 Takeda K , Hayakawa Y , Van Kaer L , et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000; 97: 5498-503.","DOI":"10.1073\/pnas.040566697"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB3","doi-asserted-by":"crossref","unstructured":"3.\u2002 Kusters S , Gantner F , Kunstle G , Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111: 462-71.","DOI":"10.1053\/gast.1996.v111.pm8690213"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB4","doi-asserted-by":"crossref","unstructured":"4.\u2002 Watanabe Y , Morita M , Akaike T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996; 24: 702-10.","DOI":"10.1002\/hep.510240338"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB5","unstructured":"5.\u2002 Gantner F , Leist M , Lohse AW , Germann PG , Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-8."},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB6","doi-asserted-by":"crossref","unstructured":"6.\u2002 Kaneko Y , Harada M , Kawano T , et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000; 191: 105-14.","DOI":"10.1084\/jem.191.1.105"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB7","doi-asserted-by":"crossref","unstructured":"7.\u2002 Mizuhara H , Uno M , Seki N , et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996; 23: 1608-15.","DOI":"10.1053\/jhep.1996.v23.pm0008675184"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB8","doi-asserted-by":"crossref","unstructured":"8.\u2002 Nicoletti F , Zaccone P , Xiang M , et al. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine 2000; 12: 315-23.","DOI":"10.1006\/cyto.1999.0561"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u2002 Tagawa Y , Sekikawa K , Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(\u2212\/\u2212) mice, but not in TNF-alpha(\u2212\/\u2212) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 1997; 159: 1418-28.","DOI":"10.4049\/jimmunol.159.3.1418"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB10","doi-asserted-by":"crossref","unstructured":"10.\u2002 Toyabe S , Seki S , Iiai T , et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997; 159: 1537-42.","DOI":"10.4049\/jimmunol.159.3.1537"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u2002 Jaruga B , Hong F , Sun R , Radaeva S , Gao B. Crucial role of IL-4\/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 2003; 171: 3233-44.","DOI":"10.4049\/jimmunol.171.6.3233"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB12","doi-asserted-by":"crossref","unstructured":"12.\u2002 Brock JH. The physiology of lactoferrin. Biochem Cell Biol 2002; 80: 1-6.","DOI":"10.1139\/o01-212"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB13","unstructured":"13.\u2002 Levay PF , Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80: 252-67."},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u2002 Masson PL , Heremans JF. Lactoferrin in milk from different species. Comp Biochem Physiol B 1971; 39: 119-29.","DOI":"10.1016\/0305-0491(71)90258-6"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB15","doi-asserted-by":"crossref","unstructured":"15.\u2002 Cumberbatch M , Dearman RJ , Uribe-Luna S , et al. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 2000; 100: 21-8.","DOI":"10.1046\/j.1365-2567.2000.00014.x"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB16","doi-asserted-by":"crossref","unstructured":"16.\u2002 Togawa J , Nagase H , Tanaka K , et al. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol Gastrointest Liver Physiol 2002; 283: G187-95.","DOI":"10.1152\/ajpgi.00331.2001"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB17","doi-asserted-by":"crossref","unstructured":"17.\u2002 Van Snick JL , Masson PL. The binding of human lactoferrin to mouse peritoneal cells. J Exp Med 1976; 144: 1568-80.","DOI":"10.1084\/jem.144.6.1568"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB18","unstructured":"18.\u2002 Mazurier J , Legrand D , Hu WL , Montreuil J , Spik G. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur J Biochem 1989; 179: 481-7."},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB19","doi-asserted-by":"crossref","unstructured":"19.\u2002 Li KJ , Lu MC , Hsieh SC , et al. Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+ T cells and its modulation on Th1\/Th2 cytokine production. J Leukoc Biol 2006; 80: 350-8.","DOI":"10.1189\/jlb.1105668"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB20","doi-asserted-by":"crossref","unstructured":"20.\u2002 Griffiths CE , Cumberbatch M , Tucker SC , et al. Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br J Dermatol 2001; 144: 715-25.","DOI":"10.1046\/j.1365-2133.2001.04125.x"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB21","doi-asserted-by":"crossref","unstructured":"21.\u2002 Tsuda H , Sekine K , Fujita K , Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem Cell Biol 2002; 80: 131-6.","DOI":"10.1139\/o01-239"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB22","doi-asserted-by":"crossref","unstructured":"22.\u2002 Kaito M , Iwasa M , Fujita N , et al. Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin. J Gastroenterol Hepatol 2007; 22: 1894-7.","DOI":"10.1111\/j.1440-1746.2007.04858.x"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB23","doi-asserted-by":"crossref","unstructured":"23.\u2002 Yin H , Cheng L , Langenbach R , Ju C. Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury. Hepatology 2007; 45: 159-69.","DOI":"10.1002\/hep.21493"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB24","doi-asserted-by":"crossref","unstructured":"24.\u2002 Hatada S , Ohta T , Shiratsuchi Y , Hatano M , Kobayashi Y. A novel accessory role of neutrophils in concanavalin A-induced hepatitis. Cell Immunol 2005; 233: 23-9.","DOI":"10.1016\/j.cellimm.2005.03.003"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB25","doi-asserted-by":"crossref","unstructured":"25.\u2002 Lee SH , Park SW , Pyo CW , et al. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line. Biochimie 2009; 91: 102-8.","DOI":"10.1016\/j.biochi.2008.05.004"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB26","doi-asserted-by":"crossref","unstructured":"26.\u2002 Bonder CS , Ajuebor MN , Zbytnuik LD , Kubes P , Swain MG. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 2004; 172: 45-53.","DOI":"10.4049\/jimmunol.172.1.45"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB27","doi-asserted-by":"crossref","unstructured":"27.\u2002 Ajuebor MN , Hogaboam CM , Le T , Proudfoot AE , Swain MG. CCL3\/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 2004; 34: 2907-18.","DOI":"10.1002\/eji.200425071"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB28","doi-asserted-by":"crossref","unstructured":"28.\u2002 Shimazaki K , Tanaka T , Kon H , et al. Separation and characterization of the C-terminal half molecule of bovine lactoferrin. J Dairy Sci 1993; 76: 946-55.","DOI":"10.3168\/jds.S0022-0302(93)77421-4"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB29","doi-asserted-by":"crossref","unstructured":"29.\u2002 Ashorn RG , Eskola J , Tuohimaa PJ , Krohn KJ. Effect of the progesterone-inducible proteins human lactoferrin and chicken avidin on lymphocyte proliferation. Hum Reprod 1986; 1: 149-51.","DOI":"10.1093\/oxfordjournals.humrep.a136371"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB30","doi-asserted-by":"crossref","unstructured":"30.\u2002 Cho JK , Azuma N , Lee CH , Yu JH , Kanno C. Purification of membrane-bound lactoferrin from the human milk fat globule membrane. Biosci Biotechnol Biochem 2000; 64: 633-5.","DOI":"10.1271\/bbb.64.633"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB31","doi-asserted-by":"crossref","unstructured":"31.\u2002 Komine K , Kuroishi T , Ozawa A , et al. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontitis patients. Mol Immunol 2007; 44: 1498-508.","DOI":"10.1016\/j.molimm.2006.09.003"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB32","doi-asserted-by":"crossref","unstructured":"32.\u2002 Kobayashi S , Sato R , Aoki T , et al. Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection. J Vet Med Sci 2008; 70: 429-35.","DOI":"10.1292\/jvms.70.429"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB33","doi-asserted-by":"crossref","unstructured":"33.\u2002 Miyauchi H , Kaino A , Shinoda I , Fukuwatari Y , Hayasawa H. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer's patch cells. J Dairy Sci 1997; 80: 2330-9.","DOI":"10.3168\/jds.S0022-0302(97)76184-8"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB34","doi-asserted-by":"crossref","unstructured":"34.\u2002 Lohr HF , Schlaak JF , Gerken G , et al. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161-6.","DOI":"10.1111\/j.1600-0676.1994.tb00067.x"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB35","unstructured":"35.\u2002 Martinez OM , Villanueva JC , Gershwin ME , Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-9."},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB36","doi-asserted-by":"crossref","unstructured":"36.\u2002 Prendiville J , Thatcher N , Lind M , et al. Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer - a phase I toxicity study and pharmacokinetic analysis. Eur J Cancer 1993; 29A: 1700-7.","DOI":"10.1016\/0959-8049(93)90108-R"},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB37","unstructured":"37.\u2002 Leach MW , Snyder EA , Sinha DP , Rosenblum IY. Safety evaluation of recombinant human interleukin-4. I. Preclinical studies. Clin Immunol Immunopathol 1997; 83: 8-11."},{"key":"10.1111\/j.1478-3231.2009.02199.x-BIB38","doi-asserted-by":"crossref","unstructured":"38.\u2002 Guillot C , Coathalem H , Chetritt J , et al. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis. J Immunol 2001; 166: 5225-35.","DOI":"10.4049\/jimmunol.166.8.5225"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02199.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2009.02199.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T20:47:08Z","timestamp":1685393228000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02199.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02199.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}